Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed under related topics, and a related topics section references MedlinePlus Genetics. This improves cross-links to additional disease information without altering the study data.
    Difference
    0.2%
    Check dated 2026-07-14T05:51:29.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study's recruitment status was updated from Active, not recruiting to Completed, and the completion dates were set to 2026-07-01 with a new revision (v3.6.3).
    Difference
    0.7%
    Check dated 2026-07-07T02:40:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-29T17:38:12.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a recruitment status update ('No longer looking for participants'), adds help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), and updates the Intervention/Treatment heading formatting along with the revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:40:42.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a Related topics section with MedlinePlus Genetics and updated the page revision from v3.5.4 to v3.5.5, indicating a minor metadata refresh.
    Difference
    0.2%
    Check dated 2026-06-08T03:43:47.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Removed the disease label 'Multiple Myeloma' under Conditions, the 'related topics' section header, and the 'MedlinePlus Genetics' resource link. This changes how the study's focus is presented and where users can access background health information on the page.
    Difference
    0.2%
    Check dated 2026-05-24T14:25:30.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.